1.Liégeois JF, Bruhwyler J, Damas J, Nguyen TP, Chleide EM, Mercier MG, Rogister FA, Delarge JE.. (1993) New pyridobenzodiazepine derivatives as potential antipsychotics: synthesis and neurochemical study., 36 (15):[PMID:8101877][10.1021/jm00067a009]
2.Warawa EJ, Migler BM, Ohnmacht CJ, Needles AL, Gatos GC, McLaren FM, Nelson CL, Kirkland KM.. (2001) Behavioral approach to nondyskinetic dopamine antagonists: identification of seroquel., 44 (3):[PMID:11462978][10.1021/jm000242+]
3.Liégeois JF, Rogister FA, Bruhwyler J, Damas J, Nguyen TP, Inarejos MO, Chleide EM, Mercier MG, Delarge JE.. (1994) Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study., 37 (4):[PMID:7907148][10.1021/jm00030a011]
4.Smits RA, Lim HD, Stegink B, Bakker RA, de Esch IJ, Leurs R.. (2006) Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives., 49 (15):[PMID:16854056][10.1021/jm051008s]
5.Vischer HF, Hulshof JW, Hulscher S, Fratantoni SA, Verheij MH, Victorina J, Smit MJ, de Esch IJ, Leurs R.. (2010) Identification of novel allosteric nonpeptidergic inhibitors of the human cytomegalovirus-encoded chemokine receptor US28., 18 (2):[PMID:20031418][10.1016/j.bmc.2009.11.060]